Literature DB >> 16220227

Hypertrophic cardiomyopathy in systemic sclerosis. A report of two cases.

I Moyssakis1, D P Papadopoulos, G Anastasiadis, P Vlachoyannopoulos.   

Abstract

We describe two patients with diffuse systemic sclerosis (SSc) where the echocardiogram revealed asymmetric hypertrophy of the interventricular septum with signs of subaortic obstruction consistent with hypertrophic obstructive cardiomyopathy. Hypertrophic cardiomyopathy is associated with the human lymphocyte antigen (HLA DR3), and this may provide a possible link with SSc, as this HLA phenotype is common in the latter condition. However, further studies should examine whether a true association exists.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16220227     DOI: 10.1007/s10067-005-0011-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

1.  Hypertrophic cardiomyopathy in systemic lupus erythematosus.

Authors:  G P Anastasiadis; I Moyssakis; K Boki; M Kyriakidis
Journal:  Mayo Clin Proc       Date:  2001-01       Impact factor: 7.616

2.  Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).

Authors:  D Falkner; J Wilson; N Fertig; K Clawson; T A Medsger; P A Morel
Journal:  J Rheumatol       Date:  2000-05       Impact factor: 4.666

3.  Echocardiographic features of progressive systemic sclerosis (PSS). Correlation with hemodynamic and postmortem studies.

Authors:  J W Smith; P J Clements; J Levisman; D Furst; M Ross
Journal:  Am J Med       Date:  1979-01       Impact factor: 4.965

4.  HLA-DR3 antigen linkage in patients with hypertrophic obstructive cardiomyopathy.

Authors:  S Fiorito; C Autore; P V Fragola; M Purpura; D Cannata; M Sangiorgi
Journal:  Am Heart J       Date:  1986-01       Impact factor: 4.749

5.  Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response.

Authors:  C G Kallenberg; J M Van der Voort-Beelen; J D'Amaro; T H The
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

6.  Non-invasive assessment of left ventricular diastolic function in patients with systemic sclerosis.

Authors:  E Kazzam; A Waldenström; J Landelius; R Hällgren; A Arvidsson; K Caidahl
Journal:  J Intern Med       Date:  1990-08       Impact factor: 8.989

7.  Polyarteritis nodosa and hypertrophic obstructive cardiomyopathy. A true association?

Authors:  Dimitris P Papadopoulos; Ioannis Moyssakis; Vassilios E Votteas
Journal:  Clin Rheumatol       Date:  2003-11-07       Impact factor: 2.980

8.  Hypertrophic cardiomyopathy in systemic lupus erythematosus and "lupus-like" disease. Chance association? A report of 2 cases.

Authors:  R A Asherson; D Ames; J Coltart; C Byrne; G R Hughes
Journal:  J Rheumatol       Date:  1992-12       Impact factor: 4.666

9.  Diversity of myocardial involvement in systemic sclerosis: an 8-year study of 95 Japanese patients.

Authors:  I Murata; K Takenaka; S Shinohara; T Suzuki; T Sasaki; K Yamamoto
Journal:  Am Heart J       Date:  1998-06       Impact factor: 4.749

10.  Cardiac involvement in systemic sclerosis.

Authors:  A Anvari; W Graninger; B Schneider; H Sochor; H Weber; H Schmidinger
Journal:  Arthritis Rheum       Date:  1992-11
View more
  1 in total

1.  A case of mixed connective tissue disease complicated with hypertrophic obstructive cardiomyopathy.

Authors:  Hideki Nakamura; Seiko Tateishi; Atsushi Kawakami; Hiroaki Ida; Taku Fukuda; Michiyo Sasaki; Yuji Koide; Naoto Ashizawa; Shinji Seto; Tomayoshi Hayashi; Shinichi Sato; Katsumi Eguchi
Journal:  Rheumatol Int       Date:  2008-05-21       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.